Summary slide.png (83.22 kB)

Long-Term Cost-Effectiveness Analyses of Empagliflozin versus Oral Semaglutide, in Addition to Metformin, For the Treatment of Type 2 Diabetes in the UK

Download (83.22 kB)
media
posted on 21.07.2020, 08:58 by Mafalda Ramos, Michael H. Cummings, Anastasia Ustyugova, Syed I. Raza, Shamika U. de Silva, Mark Lamotte

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Exports